Educational Resources for Physicians 

Many patients face delayed diagnosis. ARC is committed to educational programs to advance physician understanding, leading to earlier diagnosis and better treatment for patients. The resources in this section are created by experts and cover the the most current science and understanding of amyloidosis. 


Cardiac Amyloidosis Alert Card

 Click image to access content

Click image to access content

Download an easy-to-use pocket card showing the red flags for AL amyloidosis.

Cardiac Amyloidosis: Stop Missing It! A Multi-Disciplinary Approach to a Not so Rare Disease 

 Click image to access content

Click image to access content

CME 1.5 Credits

Martha Grogan, MD
Larry D. Anderson Jr., MD, PhD
Mazen Hanna, MD
Grace Lin, MD
Ronald M. Witteles, MD,

Date of Release: September 13, 2017
Program End Date: September 12, 2019


Diagnosing and Managing Light-Chain Amyloidosis: What the Cardiologist Needs to Know            Free - CME Credits

 click on image to access content

click on image to access content

Expert presentations by: 

Giovanni Palladini, MD PhD

Mathew Maurer, MD


Controversies in AL and ATTR Amyloidosis

The XVth International Symposium on Amyloidosis in Uppsala, Sweden. This satellite symposium held on 5th July, 2016 was made possible through an educational  grant from Prothena Corporation.

Date of Recording: July 5, 2016

Welcome and Introduction

 Giampaolo Merlini, MD

Giampaolo Merlini, MD

 

Is NT-proBNP a relevant biomarker for ATTR amyloidosis?

 Martha Grogan, MD

Martha Grogan, MD

 Mathew Maurer, MD

Mathew Maurer, MD

 Claudio Rapezzi, MD

Claudio Rapezzi, MD

 Panel Discussion         Moderator: Morie Gertz, MD

Panel Discussion         Moderator: Morie Gertz, MD


Neuropathy: Is there a difference in the natural history of AL compared with ATTR amyloidosis?

 Teresa Coelho, MD

Teresa Coelho, MD

 Ernst-Fritz Hund, MD

Ernst-Fritz Hund, MD

 Violaine Plante-Bordeneuve, MD

Violaine Plante-Bordeneuve, MD

 Panel Discussion        Moderator: Giampaolo Merlini

Panel Discussion        Moderator: Giampaolo Merlini


How should we define progression in AL amyloidosis and when should we retreat patients?

 Angela Dispenzieri, MD

Angela Dispenzieri, MD

 Heather Landau, MD

Heather Landau, MD

 Giovanni Palladini, MD

Giovanni Palladini, MD

 Panel Discussion:         Moderator Giampaolo Merlini

Panel Discussion:         Moderator Giampaolo Merlini